Medtronic PLC (MDT)

Debt-to-capital ratio

Apr 26, 2024 Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021 Apr 30, 2021 Jan 29, 2021 Oct 30, 2020 Jul 31, 2020 Apr 24, 2020 Jan 24, 2020 Oct 25, 2019 Jul 26, 2019
Long-term debt US$ in thousands 21,700,000 21,100,000 20,100,000 22,900,000 26,500,000 28,000,000 29,200,000 28,600,000 30,800,000 29,900,000 28,900,000 22,140,000 27,500,000 27,300,000 27,800,000
Total stockholders’ equity US$ in thousands 50,214,000 51,792,000 51,460,000 51,178,000 51,483,000 51,441,000 51,880,000 52,672,000 52,551,000 52,542,000 51,991,000 51,486,000 51,428,000 50,758,000 50,164,000 50,296,000 50,737,000 51,808,000 50,578,000 50,363,000
Debt-to-capital ratio 0.00 0.00 0.00 0.00 0.30 0.00 0.29 0.28 0.30 0.34 0.35 0.36 0.36 0.38 0.37 0.36 0.30 0.35 0.35 0.36

April 26, 2024 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $50,214,000K)
= 0.00

The debt-to-capital ratio for Medtronic PLC has varied over the past few years. From July 2019 to January 2020, the ratio ranged between 0.30 and 0.35, indicating a stable level of debt relative to capital during that period. However, in April 2020, there was a slight increase in the ratio to 0.36, which was maintained until October 2020.

From January 2021 to April 2021, there was another uptick in the debt-to-capital ratio to 0.38, which then stabilized around 0.36 from July 2021 to January 2022. Subsequently, the ratio decreased slightly to 0.34 in April 2022 and then fluctuated around 0.30 from July 2022 to January 2024.

Notably, in April 2023, there was a significant spike in the debt-to-capital ratio to 0.30, which then rose to 0.35 by October 2023, before decreasing to 0.29 in January 2024. Finally, the ratio dropped to 0.00 in April 2024, suggesting a significant reduction in debt relative to capital.

Overall, the trend in the debt-to-capital ratio for Medtronic PLC shows fluctuations over the analyzed periods, with some increases and decreases in the company's debt burden relative to its capital structure. It is essential for stakeholders to closely monitor these fluctuations to assess the company's financial leverage and risk profile.


Peer comparison

Apr 26, 2024


See also:

Medtronic PLC Debt to Capital (Quarterly Data)